History

2002

Integromics founded

Integromics was founded as a spin-off of the National Center for Biotechnology (CNB / CSIC) in Spain and the University of Malaga. Principal founder Dr Jose Maria Carazo was motivated by a clear market need to develop new computational methods for analyzing data, with the Company’s first product addressing the needs of the microarray data analysis market (ArrayHub).

2007

Integromics partners with AB and establishes a US Office

The Company founded a US sales and marketing subsidiary in Philadelphia. In the same year, it launched a second product for the analysis of data from qPCR instruments (RealTime StatMiner^®), and signed a major co-marketing agreement with Applied Biosystems to promote RealTime StatMiner^®.

2008

Integromics partners with TIBCO Spotfire to develop IBD

Integromics entered into a co-development deal with TIBCO Spotfire to build Integromics Biomarker Discovery^®, a new product for functional genomics based on the new TIBCO Spotfire analytics and visualization platform. A year later, the two companies entered into a distribution agreement to sell each other’s products into the life sciences market.

2009

Integromics releases its first proteomics product

Integromics received a venture investment of 1M€ from I + D Unifondo. The Company’s first proteomics product, OmicsHub^® Proteomics – a LIMS-like product that organizes and analyzes mass spectroscopy-based proteomics data – was launched.

2011

Integromics and Ingenuity expand their co-operation with the integration of a fourth Integromics product to Ingenuity's IPA

Integromics has extended its partnership with Ingenuity®, a provider of information and analytics solutions for life science researchers. The partnership extension involves the scheduled integration of Integromics' fourth product, SeqSolve™ to offer the most complete collection of Omics tools integrated with Ingenuity's IPA® software.

2011

Integromics partners with FPGMX to develop low-cost methods for clinical genomics

Integromics has entered into a partnership with Professor Angel Carracedo and his team at the Galician Foundation of Genomic Medicine (FPGMX), a recipient of the European Life Technologies ‘Ion Torrent Visionary Winners Award’, for the development of inexpensive solutions for clinical genomics.